The label is contested, the thresholds differ between guidelines, and most people who have it never progress. It is also the one point in this whole condition where a trial showed you can change the outcome by more than half.
Type 1 and type 2 are the two everyone knows. LADA is regularly mistaken for type 2 in adults, and MODY is a single-gene condition that can sometimes be treated with a tablet instead of insulin. The label decides the therapy.
A health ministry does not issue a public warning about an eating plan for the sake of it. This one followed reports of people reaching intensive care after stopping insulin.
Telling people to eat differently is one thing. Telling type 1 diabetics they can stop injecting is another, and it is the claim that brought regulators down on nizam al-tayyibat.
A UAE medical report found a natural death from sudden cardiac arrest. Egypt then exhumed the body for a second examination. Both of those facts are true, and neither cancels the other.
He trained in intensive care, built an audience of millions, was struck off by his own syndicate, and died in a Dubai hotel room at 47. The arguments about him did not stop there.